forecast
GLP-1 Drugs May Cut Cardiovascular Risk 20-30%
Early studies of GLP-1 drugs suggest a 20% to 30% benefit against cardiovascular disease, the top US killer, so they could have the largest impact on American life expectancy in a very long time, though this will take time.
forecastpending
Speaker
RodEvidence Quote
“All the early studies we've seen so far from the GLPs say you're going to get 20% to 30% benefit.”
Created: 11/13/2026, 1:54:32 PM
Your notes
Loading notes...